Singer, MD, discusses promising results for migaldendranib for the treatment of wet age-related macular degeneration and diabetic macular edema. LOS ANGELES — In this Healio Video Perspective ...

Vakharia insights from the ARCHER trial on geographic atrophy treatment for dry AMD, highlighting promising results and ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

An oral investigational agent, gildeuretinol (ALK-001), demonstrated a significant reduction in geographic atrophy (GA) ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Dr Michael Ekuoba Gyasi, Executive Director of St. Thomas Eye Hospital, was honored as CEO of the Year in Health Care – Eye ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the ...

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies into the clinic.

Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blin ...

Refalo-Azzopardi, S. and Caruana, C. (2025) Case Report: High Intraocular Pressure vs Temporal Arteritis, a Diagnostic ...